|
|
|
Volumn 23, Issue 2 SUPPL. 5, 1996, Pages 48-52
|
|
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: A phase I study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIEMETIC AGENT;
CISPLATIN;
DNA TOPOISOMERASE;
GEMCITABINE;
HYDROXYUREA;
IFOSFAMIDE;
ISOMERASE INHIBITOR;
NAVELBINE;
NIMUSTINE;
PACLITAXEL;
RADIOSENSITIZING AGENT;
TAXANE DERIVATIVE;
VINCA ALKALOID;
VINDESINE;
ADULT;
ADVANCED CANCER;
AGED;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG TOLERANCE;
ESOPHAGITIS;
ESOPHAGUS CANCER;
FEMALE;
HUMAN;
LUNG CANCER;
MALE;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
SEPSIS;
THORAX CANCER;
THYROID CANCER;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW;
CISPLATIN;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
DRUG TOLERANCE;
ESOPHAGITIS;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEUTROPENIA;
RADIATION INJURIES;
RADIATION-SENSITIZING AGENTS;
VINBLASTINE;
|
|
EID: 0029922319
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (0)
|
